Longitudinal changes of SARA scale in Friedreich ataxia: Strong influence of baseline score and age at onset

Author:

Porcu Luca1,Fichera Mario2,Nanetti Lorenzo2,Rulli Eliana3,Giunti Paola4,Parkinson Michael H.4,Durr Alexandra5,Ewenczyk Claire5,Boesch Sylvia6,Nachbauer Wolfgang6,Indelicato Elisabetta6ORCID,Klopstock Thomas789,Stendel Claudia78ORCID,Rodríguez de Rivera Francisco Javier10,Schöls Ludger1112,Fleszar Zofia11,Giordano Ilaria13,Didszun Claire14,Castaldo Anna2,Rai Myriam15,Klockgether Thomas1316,Pandolfo Massimo1517,Schulz Jörg B.1418ORCID,Reetz Kathrin1418ORCID,Mariotti Caterina2ORCID,

Affiliation:

1. Cancer Research UK Cambridge Institute University of Cambridge Cambridge UK

2. Unit of Medical Genetics and Neurogenetics Fondazione IRCCS Istituto Neurologico Carlo Besta Milan 20133 Italy

3. Laboratory of Methodology for Clinical Research, Oncology Department Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy

4. Department of Clinical and Movement Neurosciences Ataxia Centre, UCL‐Queen Square Institute of Neurology London WC1N 3BG UK

5. Sorbonne Université, Paris Brain Institute (ICM Institut du Cerveau), AP‐HP, INSERM, CNRS University Hospital Pitié‐Salpêtrière Paris 75646 France

6. Department of Neurology Medical University Innsbruck Innsbruck 6020 Austria

7. Department of Neurology Friedrich Baur Institute, University Hospital, LMU Munich 80336 Germany

8. German Center for Neurodegenerative Diseases (DZNE) Munich 81377 Germany

9. Munich Cluster for Systems Neurology (SyNergy) Munich 81377 Germany

10. Reference Unit of Hereditary Ataxias and Paraplegias, Department of Neurology IdiPAZ, Hospital Universitario La Paz Madrid 28046 Spain

11. Department of Neurology and Hertie‐Institute for Clinical Brain Research University of Tübingen Tübingen 72076 Germany

12. German Center for Neurodegenerative Diseases (DZNE) Tübingen 72076 Germany

13. Department of Neurology University Hospital of Bonn Bonn 53127 Germany

14. Department of Neurology RWTH Aachen University Aachen 52074 Germany

15. Laboratory of Experimental Neurology Université Libre de Bruxelles Brussels 1070 Belgium

16. German Center for Neurodegenerative Diseases (DZNE) Bonn 53127 Germany

17. Department of Neurology and Neurosurgery McGill University Montreal QC H3A 0G4 Canada

18. JARA Brain Institute Molecular Neuroscience and Neuroimaging, Research Centre Jülich and RWTH Aachen University Aachen 52056 Germany

Abstract

AbstractBackgroundThe Scale for Assessment and Rating of Ataxia (SARA) is widely used in different types of ataxias and has been chosen as the primary outcome measure in the European natural history study for Friedreich ataxia (FA).MethodsTo assess distribution and longitudinal changes of SARA scores and its single items, we analyzed SARA scores of 502 patients with typical‐onset FA (<25 years) participating in the 4‐year prospective European FA Consortium for Translational Studies (EFACTS). Pattern of disease progression was determined using linear mixed‐effects regression models. The chosen statistical model was re‐fitted in order to estimate parameters and predict disease progression. Median time‐to‐change and rate of score progression were estimated using the Kaplan–Meier method and weighted linear regression models, respectively.ResultsSARA score at study enrollment and age at onset were the major predictive factors of total score progression during the 4‐year follow‐up. To a less extent, age at evaluation also influenced the speed of SARA progression, while disease duration did not improve the prediction of the statistical model. Temporal dynamics of total SARA and items showed a great variability in the speed of score increase during disease progression. Gait item had the highest annual progression rate, with median time for one‐point score increase of 1 to 2 years.InterpretationAnalyses of statistical properties of SARA suggest a variable sensitivity of the scale at different disease stages, and provide important information for population selection and result interpretation in future clinical trials.

Funder

Ministero della Salute

European Commission

Voyager Therapeutics

Publisher

Wiley

Subject

Neurology (clinical),General Neuroscience

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3